AstraZeneca to acquire Alexion in $39 billion deal

Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca
American Depositary Shares per Alexion share.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-to-acquire-alexion-in-39-billion-deal/articleshow/79697059.cms

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Right Tool for the Job: Foreign Policy Effectiveness and Nuclear Proliferation